Meta-analysis of new treatment strategies for metastatic colorectal cancer.
Parvez
Tariq
T
Department of Oncology, King Fahad Hospital, Al Madina Al Munawra, Kingdom of Saudi Arabia. tariq_parvez52@hotmail.com
Mahrous
Abdul Rehman Saleh
AR
Fawazi
Adel
A
D019883:Alkyl and Aryl Transferases / Q000037:antagonists & inhibitors; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D051231:Farnesyltranstransferase; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D009944:Organoplatinum Compounds / Q000627:therapeutic use*; D000077150:Oxaliplatin; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D042461:Vascular Endothelial Growth Factor A; D000077150:Oxaliplatin; D019883:Alkyl and Aryl Transferases; D051231:Farnesyltranstransferase; D066246:ErbB Receptors; D005472:Fluorouracil